Mount Sinai Respiratory Institute Presents:

Advances in Pulmonary Medicine 2025  

Attending this multi-day live event is a unique opportunity for physicians to stay at the forefront of pulmonary medicine, deepen their expertise, and enhance patient outcomes. With rapidly evolving treatment options and guidelines, including the use of biologics for asthma, advancements in managing interstitial lung diseases, and cutting-edge approaches for lung cancer detection and treatment, this event will provide essential, evidence-based insights that directly impact clinical practice. Physicians will gain practical knowledge on optimizing care for complex conditions like COPD, pulmonary fibrosis, and thromboembolic diseases, as well as mastering new diagnostic tools and treatment strategies. This event is worth 10.5 AMA PRA Category 1 Credits™.

November 6 - 7, 2025 

_____________________________________________________________________________________________________ 

DAILY AGENDA

~ DAY 1 ~

8:00 AM | Sign Up  

Proceed to 3rd Floor Library

 

8:15 - 8:55 AM | Breakfast Program 

3rd Floor Library

Non-CME PRODUCT THEATER

 

9:00 AM | Introduction: Dr Charles Powell 

 

9:05 - 9:45 AM | Asthma Honorary Lecture 

“Asthma and Precision Medicine: Where Are We in 2025”

Dr Monica Kraft

 

9:45 - 10:30 AM | Asthma Topics 

1. Clinical Remission In Asthma: A New Era Of Treating To Target

2. The Role of Biomarker Assessment in Mild To Moderate Asthma: Assessing Risk in
Primary and Specialty Care

3. How Should We Be Monitoring Quality of Care in Asthma?

Dr Linda Rogers/Dr Sonali Bose/Dr Boram Kim

 

10:30 - 11:15 AM | Coffee Break in Exhibit Area  

 

11:15 AM - 12:00 PM | Visiting Professor Keynote Address: Lung Cancer Detection 

The Phyllis Barlia and Family Pulmonary Lecture

Peter Mazzone MD MPH

Director Lung Cancer Program

Respiratory Institute, Cleveland Clinic Ohio

 

12:00 - 12:30 PM | Honorary Lung Cancer Lecture 

Role of the Pulmonologist in the Diagnosis and Management of Lung Cancer

Dr Charles Powell

 

12:30 - 1:00 PM | Lung Cancer Biomarker Development and Evaluation 

Peter Mazzone MD MPH

 

1:00 - 2:30 PM | Lunch Program 

3rd Floor Library

2 Non-CME PRODUCT THEATERS

 

2:30 - 3:00 PM | Emphysema and Lung Cancer: More Than Just A Coincidence 

Dr Javier Zulueta

 

3:00 - 3:30 PM | COPD: An Emerging Era of Biologics 

Dr David Steiger

 

3:30 - 4:15 PM | Challenging Asthma Patients: Presentations with Audience Response 

Dr Monica Kraft/ Dr Linda Rogers

 

4:15 - 5:00 PM | Updates in Management of Benign Central Airway Obstruction 

Udit Chaddha MD Tim Harkin MD

 

5:00 PM | Adjourn 

_____________________________________________________________________________________________________

DAILY AGENDA 

~ DAY 2 ~

 

9:00 - 9:40 AM | Breakfast Program

3rd Floor Library

Non-CME PRODUCT THEATER

 

9:45 - 10:30 AM | Thromboembolic Diseases 

1. Acute Pulmonary Embolism: Treatment and Follow Up

2. Chronic Thromboembolic Pulmonary Hypertension- CTPH

Dr Hooman Poor and Dr Shyla Saini

 

10:30 - 11:00 AM | Advances in Sleep Medicine 

Dr Oren Cohen

 

11:00 - 11:45 AM | Coffee Break in Exhibit Area  

 

11:45 AM - 12:15 PM | Interstitial Lung Disease and Lung Cancer 

Dr Maria Padilla

 

12:15 - 1:00 PM | A Challenging COPD Patient: Case Presentation with Audience Response 

Dr David Steiger/ Dr Sidney Braman

 

1:00 - 2:30 PM | Lunch Program 

3rd Floor Library

2 Non-CME PRODUCT THEATERS

 

2:30 - 3:30 PM | Multidisciplinary Case Presentations: What is Your Diagnosis? 

Dr Sakshi Dua/ Dr Adam Jacobi/ Dr Mary Beth Beasley

 

3:30 PM | Adjourn

_____________________________________________________________________________________________________ 

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to:

• Optimize the role of the pulmonologist in diagnosis and management of uncontrolled asthma and the role of biologics in asthma treatment
• Become familiar with the management of progressive pulmonary fibrosis using Stage V sarcoidosis as example of this condition
• Recognize the risk of lung cancer in patients with Interstitial Lung Disease
• Be proficient in the management of critically ill hospitalized patients with ventilator associated pneumonia
• Optimize the workup and treatment options of patients with acute pulmonary thromboembolic disease
• Recognize and manage patients with chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension
• Be proficient in using biomarkers in identifying T2 and non-T2 asthma
• Become familiar with the strategies to achieve clinical remission in asthma: a new era of treating to target.
• Become familiar with the principles of monitoring quality of care in asthma?
• Discuss and apply the current literature guidelines and future options regarding the treatment of COPD including the use of biologics for COPD.
• Become familiar with the relationship of lung cancer and pulmonary emphysema
• Become familiar with the current guidelines on the diagnosis and treatment of COPD/Bronchiectasis overlap
• Explain the clinical presentations, treatments, and outcomes of Stage IV Lung Cancer
• Outline the advances and state-of-the-art recommendations to identify and treat malignant and benign diseases of the trachea
• Explain the phenotypes of high lung cancer risk and importance of CT screening
• Identify and apply lung cancer disease biomarkers for targeted and immunotherapy
• Become familiar with the use of blood-based lung cancer detection testing
• Become familiar with advances in the diagnosis and treatment of sleep apnea

_____________________________________________________________________________________________________ 

REGISTRATION FEES

Physicians — $175.00

Industry Professional — $175.00

Mount Sinai Alumni — $140.00

Allied Health Professionals — $75.00

Residents/Fellows — Complimentary

_____________________________________________________________________________________________________ 

CONTINUING MEDICAL EDUCATION 

ACCME Accreditation: 

Master Clinicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Credit Designation: 

Master Clinicians, LLC designates this enduring material for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

_____________________________________________________________________________________________________ 

RETURN/CANCELLATION POLICY 

We understand that plans can change. Please review our refund policy below for event cancellations:

• Full Refund: Cancellations made more than 30 days before the event will receive a 100% refund, excluding a 3.5% transaction fee.
• Partial Refund: Cancellations made between 8 to 30 days prior to the event will receive a 50% refund, excluding a 3.5% transaction fee.
• No Refund: Cancellations made 7 days or fewer before the event are non-refundable.

Please note: All refunds are subject to a 3.5% transaction fee, which is non-refundable. If you have any questions regarding this policy, feel free to contact us.